Adagio Medical Director Timothy Moran Receives Stock Option Award

What Happened
Timothy P. Moran, a director of Adagio Medical Holdings, Inc. (ADGM), received an award of options covering 30,000 shares on 2026-06-16. The Form 4 records the acquisition as a derivative award (grant) with an acquisition price listed as $0.00. This was a grant of equity (not a sale or open-market purchase) under the company’s director compensation arrangements.

Key Details

• Transaction date: 2026-06-16; Form 4 filed 2026-08-12 (filing appears late).
• Award: Option covering 30,000 shares; acquisition price shown as $0.00 on the Form 4.
• Vesting: Per footnote, the option vests in equal monthly installments over one year (1/12th of the underlying shares vests at the end of each month), with a vesting commencement date of 06/16/2026.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: The option was granted under Adagio’s Non-Employee Director Compensation Policy and the 2024 Equity Incentive Plan.
• Timeliness: The filing was submitted nearly two months after the transaction date; late filings can draw investor attention and potential SEC scrutiny.

Context
This report documents a derivative grant (stock option award) to a non-employee director as part of routine director compensation. The Form 4 shows the award amount and vesting schedule; it does not indicate an immediate sale or exercise. For details on exercise price, post-vesting sale restrictions, or the company’s director pay practices, consult Adagio’s proxy statements or equity plan disclosures.